Oncolytics Biotech Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2023 | — | — | $26.4M |
| FY2024 | $10.1M | $13.4M | $11.1M |
| FY2025 | $11.4M | $7.6M | $5.2M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2023 | — | — | $26.4M |
| FY2024 | $10.1M | $13.4M | $11.1M |
| FY2025 | $11.4M | $7.6M | $5.2M |